I am very encouraged that the viral hepatitis community is getting it’s advocacy legs under it and starting to be a stronger voice, and ready to be effective at getting federal dollars for viral hepatitis. Ensuring that the HIV and hepatitis folks are working arm-in-arm on this is going to continue to be really important.
I want to hear the hepatitis people yelling as loudly as the HIV folks have been. When it comes to syringe access it’s as important, if not more important given HCV rates among injection drug users, that hepatitis advocates are clear about the importance of these programs.”—Laura Thomas from Drug Policy Alliance in an update on the federal syringe access policy. Read more at: hivandhepatitis.com - Federal Syringe Access Policy: Where Are We Now? | Injection Drug Use